Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Easy .03 in the AM..
Like as in .25?!?!?!? $VDRM $$$
Why the f are we not on breakout boards yet!!?????
Bahaha! Grand=BIGGEST laughing stock of the entire OTC!! LOL
lol!!! late to the party?!?!? See ya at .10+ $VDRM $$$$$
Everyone send to MODS and ask why we are not on the breakout boards yet?? We should be at #1
$VDRM
Hey Grand!
Where did you go ya little PUSSY!!!
Eat shit ya low life MAGGOT!!
What a LOSER!!!
BAHAHAHAHHAHAAH
Strange we're not on Breakout boards.. should be in the top 5
Sure is!! 2021 is going to be $VDRM 's year!!! $$$$$
Sure will! Companies/Hospitals will be announced soon! This is just the start! We've waited a LONG TIME for this!
$VDRM $$$$$$
Grand!! Hope you bought in chump! bank director lol is the BIGGEST LOSER in the OTC!! bahahahaha
ViaDerma Inc., Provides Review of 2020 and Looks Forward to 2021Press Release | 01/13/2021
LOS ANGELES, Jan. 13, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink:VDRM), President and CEO, Dr. Christopher Otiko offers a review of 2020 and provides a summary of his expectations for the coming year 2021.
“Despite the challenges faced by many companies, including ViaDerma during 2020, our Company has been able to make very significant strides forward that have laid the foundation for what we believe could be a record-breaking year,” said Dr. Christopher Otiko, President of ViaDerma.
Some of the highlights of the past 12 months include:
The FDA approved the registration of a new 55 ml Vitastem spray bottle. This came at the request of hospitals that have tested the product. A larger spray version will be easier to apply the medication to large wounds.
Liberdol, a new relief pain product was officially launched in 2020. The analgesics market in the U.S. is estimated to be more than $12 billion dollars.
An extended line of credit was secured for financing future manufacturing. We anticipate sales to top 500,000 units in 2021.
A large national hospital chain and a major health insurance company have completed successful testing of the Vitastem product. We are now in the final stages of discussions to determine the size of the initial purchase.
Successful product testing was completed by a major midwestern university with whom we are also in discussions regarding their initial product purchase.
We have initiated discussions with a major global medical nonprofit that has expressed interest in purchasing Vitastem for use by their doctors and medical staff in treating patients.
About ViaDerma, Inc.
ViaDerma, Inc. (OTC: VDRM) is a publicly traded specialty pharmaceutical company committed to bringing new products to market and licensing its innovative technology to current leaders in the pharmaceutical industry in a wide variety of therapeutic areas. For more information, visit: www.viadermalicensing.com
https://www.otcmarkets.com/stock/VDRM/news/ViaDerma-Inc-Provides-Review-of-2020-and-Looks-Forward-to-2021?id=286028
Lets go $VDRM $$$$$$$$
She's starting to run !! $SECI $$$
$SECI $$$$
WOW! Just checked back here!! Come on .01!!!!
$WDLF $$$
Come on .01+!!!! $WDLF $$$$
Loaded up here!!! Bought a crap load at the open!! $WDLF $$$
I'll buy all these .017's!!!! $CBBT $$$
Adding here! $CBBT $$$